Opipramol

Known as: 1-Piperazineethanol, 4-(3-(5H-dibenz(b,f)azepin-5-yl)propyl)-, Opipramol [Chemical/Ingredient] 
A tricyclic antidepressant with actions similar to AMITRIPTYLINE.
National Institutes of Health

Related topics

Related topics

11 relations

Broader (2)

Adrenergic Uptake InhibitorsTricyclic Antidepressive Agents
In BloodOpipramol Hydrochlorideagonistsanalogs & derivatives
(More)

Narrower (1)

Insidon

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Mania Induced by Opipramol
Antidepressants have propensity to induce manic switch in patients with bipolar disorder. Opipramol is an atypical anxiolytic and… (More)
Is this relevant?
Review
2015
Review
2015
Efficacy of treatments for anxiety disorders: a meta-analysis.
To our knowledge, no previous meta-analysis has attempted to compare the efficacy of pharmacological, psychological and combined… (More)
Is this relevant?
Review
2005
Review
2005
Generalised anxiety disorder.
 
Is this relevant?
2004
2004
Neuropharmacology of the anxiolytic drug opipramol, a sigma site ligand.
Although opipramol is structurally related to imipramine, it does not represent a tricyclic antidepressant drug as it does not… (More)
Is this relevant?
2003
2003
Specific modulation of sigma binding sites by the anxiolytic drug opipramol
 The atypical anxiolytic and antidepressive drug opipramol binds with high affinity to σ1 and somewhat lower affinity to σ2 sites… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2002
2002
Effects of opipramol as an evening anaesthesiologic premedication.
To date, opipramol has not been examined within the context of evening premedication in anaesthesiology. A suitable drug for such… (More)
Is this relevant?
2001
2001
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
Opipramol, a drug widely prescribed in Germany, is a tricyclic compound with no reuptake-inhibiting properties. However, it has… (More)
Is this relevant?
2000
2000
Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial
Although somatoform disorders are highly prevalent, so far there is no established pharmacological treatment. Opipramol is a… (More)
Is this relevant?
1990
1990
Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo.
Opipramol, a tricyclic antidepressant drug, potently interacted with sigma recognition sites labelled by [3H](+)-3-hydroxyphenyl… (More)
Is this relevant?
1967
1967
Suicid mit Opipramol (Insidon®)
A case of suicide with 100 tablets of Opipramol (Insidon, 5.0 g) is described. The patient was admitted to the hospital 12–18… (More)
Is this relevant?